TRCT
THRN

Tower Research Capital (TRC)’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Tower Research Capital (TRC)’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,351
Closed -$13.8K – 6380
2023
Q3 		$13.8K Sell
1,351
-856
-39% -$6.52K ﹤0.01% 3751
2023
Q2 		$10.4K Sell
2,207
-231
-9% -$1.06K ﹤0.01% 4130
2023
Q1 		$11K Sell
2,438
-1,064
-30% -$4.68K ﹤0.01% 4303
2022
Q4 		$13K Buy
3,502
+738
+27% +$3.27K ﹤0.01% 3659
2022
Q3 		$13K Sell
2,764
-4,438
-62% -$22.3K ﹤0.01% 4307
2022
Q2 		$35K Buy
7,202
+4,382
+155% +$26.6K ﹤0.01% 3231
2022
Q1 		$18K Buy
2,820
+1,928
+216% +$10.4K ﹤0.01% 3660
2021
Q4 		$6K Buy
892
+769
+625% +$6.01K ﹤0.01% 5095
2021
Q3 		$1K Buy
+123
New +$1K ﹤0.01% 5588

Tower Research Capital (TRC)'s THRN Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 1,351 shares — an estimated $13.8K sold.

Tower Research Capital (TRC) first reported a position in THRN in Q3 2021 and held it in 9 quarters. The position peaked at $35K in Q2 2022. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,351 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $13.8K.
  • Tower Research Capital (TRC) first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Thorne Healthtech, Inc. Common Stock position peaked at $35K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.